Pharmafile Logo
Pharmafocus logo
Advanced Search

European biotech revenues fall back

May 20, 2004

Revenues from the European biotech sector have fallen back for the first time in 2003, as many companies across the …

News

Faslodex launched in UK

May 19, 2004
AstraZeneca, Faslodex

The latest addition to AstraZeneca’s oncology franchise, breast cancer drug Faslodex has been launched in the UK.Licensed for the treatment …

News

Obesity drug collaboration for BMS and Solvay

May 19, 2004

Bristol-Myers Squibb and Solvay are to collaborate on the development and marketing of a novel phase I compound for the …

News

NICE strikes deal with industry on data confidentiality

May 19, 2004

The industry and NICE have reached  agreement on how the cost and clinical effectiveness body can meet demands for transparency …

News

Zocor approved for sale over-the-counter

May 14, 2004

News

Clinicians still struggling to gain control of NHS

May 14, 2004

News

TNF-blockers continue to expand indications

May 14, 2004

Competitors in one of the industry's fastest growing markets, the TNF-blocker class of rheumatoid arthritis drugs, have gained extensions to …

News

New laws to combat animal rights extremists

May 14, 2004

New legislation will be introduced to combat animal rights extremists' violence against those involved in using animals in medical research.But …

News

Women returning to HRT

May 14, 2004

News

GSK sued for ‘abandoning’ Relenza

May 14, 2004

Biota, the Australian biotech company that discovered Relenza, is taking GlaxoSmithKline to court, alleging that it failed to properly launch …

News

Antisoma and Roche’s ovarian cancer drug disappoints

May 12, 2004

A phase III trial of a drug to treat ovarian cancer has disappointed and is likely to be dropped, co-developers …

News

UK and Ireland spoil Exanta’s European approval

May 11, 2004

News

Intervention from Paris secures French future for Aventis

May 7, 2004

Aventis has dropped its long-running opposition to a takeover bid by French compatriots Sanofi-Synthlabo after the offer to its shareholders …

News

OTC Zocor to be cleared but divisions persist

April 28, 2004

The government is shortly to announce the approval of the world's first over-the-counter statin, Zocor Heart Pro, but is unlikely …

News

Burson-Marsteller to launch cancer treatment in the UK

April 28, 2004

Burson-Marsteller, a subsidiary of the WPP advertising giant, has been appointed PR campaign handler for the UK launch of Velcade, …

News

NHS finances a cause for concern, says watchdog

April 28, 2004

News

Patients still being denied access to colon cancer treatments

April 28, 2004

A new Roche-sponsored survey of patients with bowel cancer has found that most are still not being consulted on the …

News

BMA chairman warns reforms add to threat of ‘two-tier NHS’

April 26, 2004

The chairman of the BMA has warned that new reforms are adding to the threat of a two-tier NHS posed …

News

US legal action Aventis’ latest weapon in repelling Sanofi

April 26, 2004

Aventis has unleashed its latest stratagem in resisting Sanofi-Synthleabo's hostile takeover bid, a US legal action claiming its rival has …

News

A tale of two pills for Pfizer in Q1

April 26, 2004
Pfizer, torceptrapib

 The first quarter of 2004 saw Pfizer’s biggest seller Lipitor extend its domination of the statin market but Viagra, another …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025